Wellness Pioneer Branches into Cannabis with Groundbreaking Technology Platform

Nature is the lifeblood of the health and wellness industry. In fact, rainforest plants account for the raw material to produce a quarter of Western pharmaceuticals, including more than 120 different drugs. The challenge is understanding natural compounds and converting them into a format that maximizes their benefits to humans.

Let’s take a look at BioHarvest Sciences Ltd.’s (CSE: BHSC) (OTC: CNVCF) (FSE: 8MV) unique approach to plant products and why investors should take a closer look at the stock.

Realizing the Benefits of Nature

Most people recognize the importance of diet to their health and well-being, but eating healthy comes with its own set of challenges. At the same time, some beneficial active ingredients are impractical to consume in sufficient quantities through diet alone. These challenges led some scientists to explore ways to better harness the power of nature.

BioHarvest scientists began with the mission of harnessing the benefits of red wine without the sugar, calories, and alcohol. After over ten years of research and $40 million in investment, the company built a scalable biofarming platform to transform a single grape cell high in Piceid Resveratrol and other polyphenols (such as catechin, quercetin, anthocyanins, and tannins) into an unlimited quantity of exact copies.

The process involves a few steps:

1. The team selects an ideal plant for the desired phytochemicals.
2. The team isolates the desired cells and inserts them into a nutrient-packed Petri dish stored in a controlled environment.
3. These cells grow into a “cell bank” used for perpetual production without the need for another live plant.
4. The cells are grown in liquid mediums for three weeks at a time to reach adequate biomass.
5. The biomass is harvested and dried into a final powder that contains the desired phytochemicals.

There are many benefits to the process:

• Less Time: Three-week cycles accomplish as much as it takes nature one year to complete with a much sharper focus.
• Less Waste: The process doesn’t involve chemicals, uses far less energy and land, and produces no hazardous waste.
• More Consistency: The process results in cells with the same genetic fingerprint as the parent plant cell.
• Better Safety: There are no dangerous chemicals or potential for plant-based infections, as occur in agriculture.

After spending more than a decade on research, the company launched VINIA®, a resveratrol supplement backed by eight scientific studies, three clinical trials, and 14 patents. The supplement provides as much resveratrol as a bottle of wine in each pill to support heart health , improve physical energy, and boost mental alertness via increased blood flow and delivery of oxygen and nutrients to the body’s tissues and organs.

Click the image below to watch a video on how Vinia® works:

[embedded content]

Expanding into Cannabinoids

BioHarvest’s unique biofarming platform can scale the production of nearly any phytochemical, making it broadly applicable across the wellness market. So, with the legalization of cannabis in Canada, the team began to explore the potential for biofarming cannabinoids to address many concerns facing the industry.

The cannabis plant has hundreds of cannabinoids and terpenes that could offer a range of benefits. While scientific research is still playing catch up, the industry’s rapid growth introduced several growing pains. Pesticides are commonplace, and the plant requires a significant amount of water and light to grow even in fully compliant grows.

Furthermore, cannabis producers only use a fraction of the plant’s biomass for most consumer products. For example, most products don’t use leaves, stalks, root balls, and failed plants. Meanwhile, growers must process flowers through various extraction techniques to get the THC, CBD, or other desired cannabinoids from the plant material.

BioHarvest’s unique platform eliminates waste and ensures product consistency on a genetic level. In addition to a much lower CapEx and smaller footprint, the company’s scalable technology removes the risk of contamination and ensures a consistent experience for consumers. It’s a win-win-win for the environment, shareholders, and consumers.

Click here to receive an investor presentation and corporate updates

Recently, the company announced that it has successfully grown multiple trichomes attached together in natural coral-shaped structures. The structure protects the trichomes from damage and guarantees mechanical stability during the growth process. Management believes that the breakthrough will help it scale up commercialization during the first half of next year.

Looking Ahead

BioHarvest plans to continue developing its cannabis commercialization program through the remainder of 2021 before starting production in 2022. With numerous other potential products, such as olives and pomegranates, and markets, such as cosmetics or proteins, the company’s addressable market could be in the hundreds of billions of dollars each year.

As part of its quest to harvest the benefits of natural resources, the company has doubled down on its commitment to nature with the release of its first sustainability report, which highlights the unique sustainability advantages of its BioFarming technology along with specific sustainability goals through 2025 along with specific benchmarks to measure success. These factors make it potentially suitable for ESG-focused portfolios.

For more information, visit the company’s website or download their investor presentation.

Disclaimer

The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.